南新制药：公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形

证券之星06-10 16:09

证券之星消息，南新制药(688189)06月10日在投资者关系平台上答复投资者关心的问题。

投资者提问：公司被ST了，会不会导致公司退市呢？

南新制药回复：尊敬的投资者，您好！公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形，仅触及实施其他风险警示的情形。截至本公告披露日，公司各项生产经营活动正常有序开展。公司将严格按照相关法律法规的要求，及时履行后续进展情况的信息披露义务。感谢您的关注和支持！

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2642446448?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-10 16:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642446448","market":"hk","top_or_hot":-1,"title":"南新制药：公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/688189\">南新制药</a>(688189)06月10日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：公司被ST了，会不会导致公司退市呢？</p><p>南新制药回复：尊敬的投资者，您好！公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形，仅触及实施其他风险警示的情形。截至本公告披露日，公司各项生产经营活动正常有序开展。公司将严格按照相关法律法规的要求，及时履行后续进展情况的信息披露义务。感谢您的关注和支持！</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>南新制药：公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n南新制药：公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-10 16:09 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026061000026926.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，南新制药(688189)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司被ST了，会不会导致公司退市呢？南新制药回复：尊敬的投资者，您好！公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形，仅触及实施其他风险警示的情形。截至本公告披露日，公司各项生产经营活动正常有序开展。公司将严格按照相关法律法规的要求，及时履行...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026061000026926.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"159982","symbol_name":"中证500","start_time":0,"source_url":"https://stock.stockstar.com/RB2026061000026926.shtml","article_id":"2642446448","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2642446448","pubTimestamp":1781078958,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，南新制药(688189)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司被ST了，会不会导致公司退市呢？南新制药回复：尊敬的投资者，您好！公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形，仅触及实施其他风险警示的情形。截至本公告披露日，公司各项生产经营活动正常有序开展。公司将严格按照相关法律法规的要求，及时履行后续进展情况的信息披露义务。感谢您的关注和支持！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159982":"中证500","688189":"南新制药","BK0239":"医药制造"},"translate_title":"Nanxin Pharmaceutical: The company's violations of laws and regulations involving information disclosure this time do not touch the compulsory delisting of major violations stipulated in the Shanghai Stock Exchange Science and Technology Innovation Board Stock Listing Rules","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1.5,"688189":1.5},"content_text":"证券之星消息，南新制药(688189)06月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司被ST了，会不会导致公司退市呢？南新制药回复：尊敬的投资者，您好！公司本次涉及信息披露违法违规行为不触及《上海证券交易所科创板股票上市规则》规定的重大违法强制退市情形，仅触及实施其他风险警示的情形。截至本公告披露日，公司各项生产经营活动正常有序开展。公司将严格按照相关法律法规的要求，及时履行后续进展情况的信息披露义务。感谢您的关注和支持！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642446448","isCrawlerRequest":true}